Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease

Current Medicinal Chemistry

Volumn 19, Issue 14, 2012, Pages 2252-2261

  Orhan, I Erdogan ^a,b  

^a GAZI UNIVERSITY   (Turkey)

^b EASTERN MEDITERRANEAN UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Cholinesterase; Enzyme inhibition; Medicinal plants; Prolyl endopeptidase; Secretase

Indexed keywords

4 HYDROXYCOUMARIN; AGRIMONIA PILOSA EXTRACT; BERGAPTEN; BETA SECRETASE INHIBITOR; CHELIDONIUM EXTRACT; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; COUMARIN DERIVATIVE; CYNATROSIDE B; DONEPEZIL; EPIGALLOCATECHIN GALLATE; GALANTAMINE; HALOXYLINE B; HUPERZINE A; ISOORIENTIN; ISOVITEXIN; LYCORINE; METHOXSALEN; PENTOSALEN; PHYSOSTIGMINE; PLANT EXTRACT; PROTOCATECHUIC ACID; QUERCITRIN; RIVASTIGMINE; ROSMARINIC ACID; SCOPOLETIN; SOPHORA FLAVESCENS EXTRACT; TACRINE; UMBELLIFERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMARYLLIDACEAE; ANGELICA; ANGELICA ARCHANGELICA; ARTICLE; CANTHARELLUS; CHELIDONIUM; CHOLINESTERASE INHIBITION; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL TRIAL (TOPIC); COPTIS CHINENSIS; CYNANCHUM; DATA ANALYSIS; EUGENIA; GALANTHUS; GRAPE; HUMAN; HUPERZIA; IC 50; MACLURA POMIFERA; MEDICAL RECORD; METABOLITE; MORUS; NELUMBO NUCIFERA; NONHUMAN; PANAX NOTOGINSENG; PHYSOSTIGMA; PLANT METABOLISM; POLYGALA TENUIFOLIA; SCOPOLIA; SOPHORA FLAVESCENS; SYZYGIUM; TABERNAEMONTANA; XYLOPIA; ZYGOPHYLLACEAE;

EID: 84860666453     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800229032     Document Type: Article

References (92)

1. Scarpini, E.; Scheltens, P.; Feldman, H. Treatment of Alzheimer's disease: Current status and new perspectives. Lancet Neurol., 2003, 2, 539-547. (Pubitemid 36994993)
2. Alzheimer's Association, Alzheimer's Disease Facts and Figures, Alzheimer's & Dementia, 2010, 6, 10-16.
3. Jalbert, J.; Daieilo, L. A.; Lapane, K. L. Dementia of the Alzheimer type. Epidemiol. Rev., 2008, 30, 15-34.
4. Francis, P. T.; Palmer, A. M.; Snape, M.; Wilcock, G. K. The cholinergic hypothesis of Alzheimer's disease. A review of progress. J. Neurol. Neurosurg. Psychiatry, 1999, 66, 137-147. (Pubitemid 29103513)
5. Deutsch, J. A. The cholinergic synapse and the site of memory. Science (Wash. DC), 1971, 174, 788-794.
6. Terry Jr., A. V.; Buccafusso, J. J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther., 2003, 306, 821-827. (Pubitemid 37025286)
7. Orhan, G.; Orhan, I.; Sener, B. Recent developments in natural and synthetic drug research for Alzheimer's disease. Lett. Drug Design Disc., 2006, 3, 268-274. (Pubitemid 43764781)
8. Wilk, S. Prolyl endopeptidase. Life Sci., 1983, 33, 2149-2157. (Pubitemid 14234451)
9. Bell, R. D.; Sagare AP, Friedman AE, et al. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab., 2007, 27, 909-918. (Pubitemid 46659038)
10. Roßner, S.; Schulz, I.; Zeitschel,U.; Schliebs,R.; Bigl, V.; Demuth, H. U. Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease. Neurochem. Res., 2005, 30, 695-702. (Pubitemid 41413928)
11. Galdeano, C.; Viayna, E.; Arroyo, P.; Bidon-Chanal, A.; Blas, J. R.; Munoz-Torrero, D.; Luque, F. J. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents. Curr. Pharm. Des., 2010,16, 2818-2836.
12. Cokugras, N. Butyrylcholinesterase: Structure and physiological importance. Turk. J. Biochem., 2003, 28, 54-61.
13. Krall, W. J.; Sramek, J. J.; Cutler, N. R. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann. Pharmacother., 1999, 33, 441-450. (Pubitemid 29215811)
14. Prvulovic, D.; Hampel, H.; Pantel, J. Galantamine for Alzheimer's disease. Expert Opin. Drug Metab. Toxicol., 2010, 6, 345-354.
15. Little, J. T.; Walsh, S.; Aisen, P. S. An update on huperzine A as a treatment for Alzheimer's disease. Expert Opin. Investig. Drugs, 2008, 17, 209-215. (Pubitemid 351578201)
16. Zangara, A. The psychopharmacology of huperzine A: An alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol. Biochem. Behav., 2003, 75, 675-686. (Pubitemid 36939173)
17. De Sarno, P.; Pomponi, M.; Giacobini, E.;. Tang, X. C.; Williams, E. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Neurochem. Res., 1989, 14, 971-977 (Pubitemid 20001602)
18. Ved, H. S.,; Koenig, M. L.; Dave, J. R.; Doctor, B. P. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neurorep., 1997, 8, 963-967.
19. Xiao, X. Q.; Yang, J. W.; Tang, X. C. Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury. Neurosci. Lett., 1999, 275, 73-76. (Pubitemid 29502539)
20. Kalauni, S. K.; Choudhary, M. I.;, Khalid, A.; Manandhar, M. D.; Shaheen, F.; Atta-ur-Rahman; Gewali, M. B. New cholinesterase inhibiting steroidal alkaloids from the leaves of Sarcococca coriacea of Nepalese origin. Chem. Pharm. Bull., 2002, 50, 1423-1426. (Pubitemid 41685604)
21. Khalid, A.; Zaheer-ul-Haq; Ghayur, M. N.; Feroz, F.; Atta-ur-Rahman; Gilani, A. H.; Choudhary, M. I. Cholinesterase inhibitory and spasmolytic potential of steroidal alkaloids. J. Steroid Biochem. Mol. Biol., 2004, 92, 477-484. (Pubitemid 40187165)
22. Lee, K. Y.; Yoon, J. S.; Kim, E. S.; Kang, S. Y.; Kim, Y. C. Antiacetylcholinesterase and anti-Amnesic activities of a pregnane glycoside, cynatroside B, from Cynanchum atratum. Planta Med., 2005, 71, 7-11. (Pubitemid 40223345)
23. Khalid, A.; Azim, M. K.; Parveen, S.; Atta-ur-Rahman; Choudhary, M. I. Structural basis of acetylcholinesterase inhibition by triterpenoidal alkaloids. Biochem. Biophys. Res. Commun., 2005, 331, 1528-1532. (Pubitemid 40692528)
24. Erdogan Orhan, I.; Khan, M. T. H.; Aslan Erdem, S.; Kartal, M.; Sener, B.; Sylte, I. Selective cholinesterase inhibitors from Buxus sempervirens L. and their molecular docking studies. Curr. Comp. Aided Drug Res. (in press).
25. Houghton, P. J.; Agbedahunsi, J. M.; Adegbulugbe, A. Cholinesterase inhibitory properties of alkaloids from two Nigerian Crinum species. Phytochemistry, 2004, 65, 2893-2896. (Pubitemid 40292121)
26. Orhan, I.; Sener, B. Bioactivity-directed fractionation of alkaloids from some Amaryllidaceae plants and their anticholinesterase activity. Chem. Nat. Compds., 2003, 39, 383-386. (Pubitemid 38982826)
27. Markmee, S.; Ruchirawat, S.; Prachyawarakorn, V.; Ingkaninan, K.; Khorana, N. Isoquinoline derivatives as potential acetylcholinesterase inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 2170-2172. (Pubitemid 43351072)
28. Ingkaninan, K.; Phengpa, P.; Yuenyongsawad, S.; Khorana, N. Acetylcholinesterase inhibitors from Stephania venosa tuber. J. Pharm. Pharmacol., 2006, 58, 695-700.
29. Cho KM, Yoo ID, Kim WG. 8-hydroxydihydrochelerythrine and 8-hydroxydihydrosanguinarine with a potent acetylcholinesterase inhibitory activity from Chelidonium majus L. Biol. Pharm. Bull., 2006, 29, 2317-2320.
30. Hung, T. M.; Ngoc, T. M.; Youn, U. J.; Min, B. S.; Na, M.; Thuong, P. T.; Bae, K. Anti-Amnestic activity of pseudocoptisine from Corydalis Tuber. Biol. Pharm. Bull., 2008, 31, 159-162.
31. Orhan, I.; Naz, Q.; Kartal, M.; Tosun, F.; Sener, B.; Choudhary, M. I. In vitro anticholinesterase activity of various alkaloids. Z. Naturforsch. C, 2007, 62, 684-688. (Pubitemid 350105018)
32. Andrade, M. T.; Lima, J. A.; Pinto, A. C.; Rezende, C. M.; Carvalho,M. P.; Epifanio, R. A. Indole alkaloids from Tabernaemontana australis (Müell. Arg.) Miers that inhibit acetylcholinesterase enzyme. Bioorg. Med. Chem., 2005, 13, 4092-4095. (Pubitemid 40725042)
33. Ferheen, S.; Ahmed, E.; Afza, N.; Malik, A.; Shah, M. R.; Nawaz, S. A.; Choudhary, M. I. Haloxylines A and B, antifungal and cholinesterase inhibiting piperidine alkaloids from Haloxylon salicornicum. Chem. Pharm. Bull., 2005, 53, 570-572. (Pubitemid 40740629)
34. Ahmad, V. U.; Iqbal, S.; Nawaz, S. A.; Choudhary, M. I.; Farooq, U.; Ali, S. T.; Ahmad, A,.; Bader, S.; Kousar, F.; Arshad, S.; Tareen, R. B. Isolation of four new pterocarpans from Zygophyllum eurypterum (Syn. Z. atriplicoides) with enzyme-inhibition properties. Chem. Biodivers., 2006, 3, 996-1003. (Pubitemid 44540932)
35. Jung, M.; Park, M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules, 2007, 12, 2130-2139.
36. Khan, M. T. H.; Orhan, I.; Senol, F. S.; Kartal, M.; Sener, B.; Dvorska, M.; Smejkal, K.; Slapetova, T. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem. Biol. Interact., 2009, 181, 383-389.
37. Orhan, I.; Senol, F. S.; Kartal, M.; Dvorska, M.; Zemlicka, M.; Smejkal, K.; Mokry, P. Cholinesterase inhibitory effects of the extracts and compounds of Maclura pomifera (Rafin.) Schneider. Food Chem. Toxicol., 2009, 47, 1747-1751.
38. Conforti, F.; Rigano, D.; Menichini, F.; Loizzo, M. R.; Senatore, F. Protection against neurodegenerative diseases of Iris pseudopumila extracts and their constituents. Fitoterapia, 2009, 80, 62-67.
39. Katalinic, M.; Rusak, G.; Domacinovic Barovic, J.; Sinko, G.; Jelic, D.; Antolovic, R.; Kovarik, Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur. J. Med. Chem., 2010, 45, 186-192.
40. Guo, A. J.; Xie, H. Q.; Choi, R. C.; Zheng, K. Y.; Bi, C. W.; Xu, S. L.; Dong, T. T.; Tsim, K. W. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro. Chem. Biol. Interact., 2010, 187, 246-248.
41. Jung, H. A.; Yokozawa, T.; Kim, B. W.; Jung, J. H.; Choi, J. S. Selective inhibition of prenylated flavonoids from Sophora flavescens against BACE1 and cholinesterases. Am. J. Chin. Med., 2010, 38, 415-429.
42. Jung, H. A.; Jin, S. E.; Park, J. S.; Choi, J. S. Antidiabetic complications and anti-Alzheimer activities of sophoflavescenol, a prenylated flavonol from Sophora flavescens, and its structure-Activity relationship. Phytother. Res., 2011, 25, 709-715.
43. Grossmann, V.; Hais, I. M.; Kasalicky, B. Inhibition of human serum cholinesterase by some 4-hydroxy-coumarin derivatives. Nature, 1950, 165, 276.
44. Brühlmann, C.; Ooms, F.; Carrupt, P. A.; Testa, B.; Catto, M.; Leonetti, F.; Altomare, C.; Carotti, A. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J. Med. Chem., 2001, 44, 3195-3198. (Pubitemid 32862350)
45. Sigurdsson, S.; Gudbjarnason, S. Inhibition of acetylcholinesterase by extracts and constituents from Angelica archangelica and Geranium sylvaticum. Z. Naturforsch. Sect. C, 2007, 62, 689-693. (Pubitemid 350105019)
46. Senol, F. S.; Skalicka Wozniak, K., Khan, M. T. H.; Erdogan Orhan, I.; Sener, B.; Glowniak, K. An in vitro and in silico approach to cholinesterase inhibitory and antioxidant effects of the methanol extract, furanocoumarin fraction, and major coumarins of Angelica officinalis L. fruits. Phytochem. Lett. (in press).
47. Kim, D. K.; Lim, J. P.; Yang, J. H.; Eom, D. O.; Eun, J. S.; Leem, H. Acetylcholinesterase inhibitors from the roots of Angelica dahurica. Arch. Pharm. Res., 2002, 25, 856-859.
48. Kang, S. Y.; Lee, K. Y.; Sung, S. L.; Park, M. J.; Kim, Y. C. Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: Structure-Activity relationships. J. Nat. Prod., 2001, 64, 683-685. (Pubitemid 32488701)
49. Kim, D. H.; Kim, D. Y.; Kim, Y. C.; Jung, J. W.; Lee, S.; Yoon, B. H.; Cheong, J. H.; Kim, Y. S.; Kang, S. S.; Ko, K. H.; Ryu, J. H. Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory distruption in mice. Life Sci., 2007, 80, 1944-1950. (Pubitemid 46628692)
50. Orhan, I.; Tosun, F.; Sener, B. Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity. Z. Naturforsch. Sect. C, 2008, 63, 366-370.
51. Rollinger, J.; Hornick, A.; Langer, T.; Stuppner, H.; Prast, H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. J. Med. Chem., 2004, 47, 6248-6254. (Pubitemid 39587249)
52. Walter, R.; Shlank, H.; Glass, J. D.; Schwartz, I. L.; Kerenyi,T. D. Leucylglycinamide released from oxytocin by human enzyme. Science, 1971, 173, 827-829.
53. Fan, W.; Tezuka, Y.; Komatsu, K.; Namba, T.; Kadota, S. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sacra S. H. Fu. Biol. Pharm. Bull., 1999, 22, 157-161. (Pubitemid 29114032)
54. Tezuka, Y.; Fan, W.; Kasimu, R.; Kadota, S. Screening of crude drug extracts for prolyl endopeptidase inhibitory activity. Phytomed., 1999, 6, 197-203. (Pubitemid 129632916)
55. Fan, W.; Tezuka, Y.; Ni, K. M.; Kadota, S. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sachalinensis. Chem. Pharm. Bull., 2001, 49, 396-401. (Pubitemid 32367670)
56. Kim, J. H.; Kim, S. I.; Song, K. S. Prolyl endopeptidase inhibitors from green tea. Arch. Pharm. Res., 2001, 24, 292-296.
57. Kobayashi, W.; Miyase, T.; Sano, M.; Umehara, K.; Warashina, T.; Noguchi, H. Prolyl endopeptidase inhibitors from the roots of Lindera strychnifolia F. Vill. Biol. Pharm. Bull., 2002, 25, 1049-1052. (Pubitemid 39663231)
58. Anis, I.; Ahmed, S.; Malik, A.; Yasin, A.; Choudary, M. I. Enzyme inhibitory constituents from Duranta repens. Chem. Pharm. Bull., 2002, 50, 515-518. (Pubitemid 41694963)
59. Chung, S. K.; Nam, J. A.; Jeon, S. Y.; Kim, S. I.; Lee, H. J.; Chung, T. H.; Song, K. S. A prolyl endopeptidase-inhibiting antioxidant from Phyllanthus ussurensis. Arch. Pharm. Res., 2003, 26, 1024-1028.
60. Amor, E. C.; Villasenor, I. M.; Yasin, A.; Choudhary, M. I. Prolyl endopeptidase inhibitors from Syzygium samarangense (Blume) Merr. & L. M. Perry. Z. Naturforsch. Sect. C, 2004, 59, 86-92. (Pubitemid 38261250)
61. Lee, J. H.; Lee, S. Y.; Lee, K. S.; Jang, H. J.; Lee, K. H.; Hahn, T. R.; Paik, Y. S. Prolyl endopeptidase inhibitors from the leaves of Ginkgo biloba. Planta Med., 2004, 70, 1228-1230.
62. Park, D. H.; Park, S. J.; Kim, J. M.; Jung, W. Y.; Ryu, J. H. Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances. Fitoterapia, 2010, 81, 644-648.
63. Song, K. S.; Raskin, I. A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex. J. Nat. Prod., 2002, 65, 76-78. (Pubitemid 34118819)
64. Kim, S. I.; Park, I. H.; Song, K. S. Kynapcin-13 and-28, new benzofuran prolyl endopeptidase inhibitors from Polyozellus multiplex. J. Antibiot., 2002, 55, 623-628.
65. Yanai, T.; Suzuki, Y.; Sato, M.; Yanai, T.; Suzuki, Y.; Sato, M. Prolyl endopeptidase inhibitory peptides in wine. Biosci. Biotechnol. Biochem., 2003, 67, 380-382. (Pubitemid 39251995)
66. Sultanova, N.; Makhmoor, T.; Yasin, A.; Abilov, Z. A.; Omurkamzinova, V. B.; Atta-Ur-Rahman; Choudhary, M. I. Isotamarixen-A new antioxidant and prolyl endopeptidase-inhibiting triterpenoid from Tamarix hispida. Planta Med., 2004, 70, 65-67. (Pubitemid 38233916)
67. Choudhary, M. I.; Ranjit, R.; Atta-Ur-Rahman; Shrestha, T. M.; Yasin, A.; Parvez, M. Leucosceptrine-A novel sesterterpene with prolylendopeptidase inhibitory activity from Leucosceptrum canum. J. Org. Chem., 2004, 69, 2906-2909. (Pubitemid 38469060)
68. Atta-ur-Rahman; Akhtar, M. N.; Choudhary, M. I.; Tsuda, Y.; Yasin, A.; Sener, B.; Parvez, M. New diterpene isopimara-7,15-dien-19-oic acid and its prolyl endopeptidase inhibitory activity. Nat. Prod. Res., 2005, 19, 13-22. (Pubitemid 40124107)
69. Atta-ur-Rahman; Naz, H.; Fadimatou, Makhmoor, T.; Yasin, A.; Fatima, N.; Ngounou, F. N.; Kimbu, S. F.; Sondengam, B. L.; Choudhary, M. I. Bioactive constituents from Boswellia papyrifera. J. Nat. Prod., 2005, 68, 189-193. (Pubitemid 40299804)
70. Diderot, N. T.; Silvere, N.; Yasin, A.; Zareen, S.; Fabien, Z.; Etienne, T.; Choudhary, M. I.; Atta-Ur-Rahman. Prolyl endopeptidase and thrombin inhibitory diterpenoids from the bark of Xylopia aethiopica. Biosci. Biotechnol. Biochem., 2005, 69, 1763-1766. (Pubitemid 41390166)
71. Sultana, N.; Khalid, A. A new fatty ester and a new triterpene from Skimmia laureola. Nat. Prod. Res., 2008, 22, 37-47. (Pubitemid 350153970)
72. Park, Y. S.; Jang, H. J.; Lee, K. H.; Hahn, T. R.; Paik, Y. S. Prolyl endopeptidase inhibitory activity of unsaturated fatty acids. J. Agric. Food Chem., 2006, 54, 1238-1242.
73. Tarrago, T.; Kichik, N.; Seguí, J.; Giralt, E. The natural product berberine is a human prolyl oligopeptidase inhibitor. ChemMedChem., 2007, 2, 354-359.
74. Xu, Y.; Gu, X.; Yuan, Z. Lignan and neolignan glycosides from the roots of Glehnia littoralis. Planta Med., 2010, 76, 1706-1709.
75. Howlett, D. R.; Simmons, D. L.; Dingwall, C.; Christie, G. In search of an enzyme: the β-secretase of Alzheimer's disease is an aspartic proteinase. Trends Neurosci., 2000, 23, 565-570.
76. Wolfe, M. S. Inhibition and modulation of γ-secretase for Alzheimer's Disease. Neurotherapeutics, 2008, 5, 391-398. (Pubitemid 351952492)
77. Annaert, W.; De Strooper, B. A cell biological perspective on Alzheimer's disease. Cell Dev. Biol., 2002, 18, 25-51. (Pubitemid 35387344)
78. Citron M. Secretases as targets for the treatment of Alzheimer's disease. Mol. Med. Today, 2000, 6, 392-397.
79. Okello, E. J.; Savelev, S. U.; Perry, E. K. In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia. Phytother. Res., 2004, 18, 624-627. (Pubitemid 39329711)
80. Lee, Y. K.; Yuk, D. Y.; Lee, J. W.; Lee, S. Y.; Ha, T. Y.; Oh, K. W.; Yun, Y. P.; Hong, J. T. Epigallocatechin-3-gallate prevents lipopolysaccharideinduced elevation of beta-Amyloid generation and memory deficiency. Brain Res., 2009, 1250, 164-174.
81. Shimmyo, Y.; Kihara, T.; Akaike, A.; Niidome, T., Sugimoto, H. Flavonols and flavones as BACE-1 inhibitors: Structure-Activity relationship in cellfree, cell-based and in silico studies reveal novel pharmacophore features. Biochim. Biophys. Acta, 2008, 1780, 819-825.
82. Paris, D.; Mathura, V.; Ait-Ghezala, G.; Beaulieu-Abdelahad, D.; Patel, N.; Bachmeier, C.; Mullan, M. Flavonoids lower Alzheimer's Aß production via an NF?B dependent mechanism. Bioinformation, 2011, 6, 229-236.
83. Zhu, Z.; Li, C.; Wang, X.; Yang, Z.; Chen, J.; Hu, L.; Jiang, H.; Shen, X. 2,2',4'-Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. J. Neurochem., 2010, 114, 374-385.
84. Sasaki, H.; Miki, K.; Kinoshita, K.; Koyama, K.; Juliawaty, L. D.; Achmad, S. A.; Hakim, E. H.; Kaneda, M.; Takahashi, K. β-Secretase (BACE-1) inhibitory effect of biflavonoids Bioorg. Med. Chem. Lett., 2010, 20, 4558-4560.
85. Lv, L.; Yang, Q. Y.; Zhao, Y.; Yao, C. S.; Sun, Y.; Yang, E. J.; Song, K. S.; Mook-Jung, I.; Fang, W. S. BACE1 (beta-secretase) inhibitory chromone glycosides from Aloe vera and Aloe nobilis. Planta Med., 2008, 74, 540-545. (Pubitemid 351655973)
86. Choi, Y. H.; Yoo, M. Y.; Choi, C. W.; Cha, M. R.; Yon, G. H.; Kwon, D. Y.; Kim, Y. S.; Park, W. K.; Ryu, S. Y. A new specific BACE-1 inhibitor from the stembark extract of Vitis vinifera. Planta Med., 2009, 75, 537-540.
87. Cho, J. K.; Ryu, Y. B.; Curtis-Long, M. J.; Kim, J. Y.; Kim, D.; Lee, S.; Lee, W. S.; Park, K. H. Inhibition and structural reliability of prenylated flavones from the stem bark of Morus ihou on β-secretase (BACE-1). Bioorg. Med. Chem. Lett., 2011, 21, 2945-2948.
88. Lv, J.; Jia, H.; Jiang, Y.; Ruan, Y.; Liu, Z.; Yue, W.; Beyreuther, K.; Tu, P.; Zhang, D. Tenuifolin, an extract derived from tenuigenin, inhibits amyloidbeta secretion in vitro. Acta Physiol. (Oxf.), 2009, 196, 419-425.
89. Wang, Y. H.; Du, G. H. Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells. J. Asian Nat. Prod. Res., 2009, 11, 604-612.
90. Jung, H. A.; Min, B. S.; Yokozawa, T.; Lee, J. H.; Kim, Y. S.; Choi, J. S. Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol. Pharm. Bull., 2009, 32, 1433-1438.
91. Jung, H. A.; Jin, SE.; Choi, R. J.; Kim, D. H.; Kim, Y. S.; Ryu, J. H.; Kim, D. W.; Son, Y. K.; Park, J. J.; Choi, J. S. Anti-Amnesic activity of neferine with antioxidant and anti-inflammatory capacities, as well as inhibition of ChEs and BACE1. Life Sci., 2010, 87, 420-430.
92. Jung, H. A.; Lee, E. J.; Kim, J. S.; Kang, S. S.; Lee, J. H.; Min, B. S.; Choi, J. S. Cholinesterase and BACE1 inhibitory diterpenoids from Aralia cordata. Arch. Pharm. Res., 2009, 32, 1399-1408.